Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Depression in Parkinson disease--epidemiology, mechanisms and management.
Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P.
Nat Rev Neurol. 2011 Dec 26;8(1):35-47. doi: 10.1038/nrneurol.2011.189. Review.
Related citations
Parkinson disease: the controversy of levodopa toxicity in Parkinson disease.
Zesiewicz TA.
Nat Rev Neurol. 2011 Dec 26;8(1):8-10. doi: 10.1038/nrneurol.2011.199. No abstract available.
Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.
Soreq L, Ben-Shaul Y, Israel Z, Bergman H, Soreq H.
Neurobiol Dis. 2012 Mar;45(3):1018-30. Epub 2011 Dec 16.
Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
Neurobiol Dis. 2012 Mar;45(3):1051-67. Epub 2011 Dec 14.
Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.
Yadav S, Gupta SP, Srivastava G, Srivastava PK, Singh MP.
Neurochem Res. 2012 Apr;37(4):875-84. Epub 2011 Dec 27.
Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D, Dowd E.
Neuroscience. 2012 Feb 17;203:170-9. Epub 2011 Dec 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on